HIV Update: Contemporary Issues in management
Why not save a little money? Get exclusive discount with coupon code: SAVE5
Key takeaways to expect:
Live-Streamed Sessions
The course will be presented in its entirety and includes real-time audience-response questions, live demonstrations and interactive Q&A sessions
Highest Rated CME
This program has sold out in previous years due to limited seating, but the new virtual platform provides the opportunity for everyone to attend, as it eliminates the need to travel
Earn AMA PRA Category 1 Credits™ and ABIM MOC points
Earn up to:
- 19.25 AMA PRA Category 1 Credits™
- 19.25 ABIM MOC Points,
- 7.5 Risk Management Credits
- 18.75 Contact Hours of Continuing Nursing Education
Health care professionals can rely on this program for the latest updates and advances in the diagnosis and management of the HIV-infected patient
Designed for
- Infectious Disease Specialists
- Primary care Physicians
- Hospitalists
- Medical Specialists
- PAs
- Nurse Practicioners
- Nurses
- Pharmacists
- Social Workers
Learning objective:
Upon completion of this course, participants will be able to:
- Evaluate current data and guidelines on post-exposure and pre-exposure prophylaxis to prevent HIV infection
- Recognie the clincial manifestations of HIV infection and describe recent advances in HIV testing
- Integrate into practice recent advances in HIV care including tailoring antiretroviral therapy based on genotype, comorbidities and potential drug interactions, appropriate incorporation of newer antiretroviral agents into treatment regimens, approaches to initial treatment and salvage antiretroviral therapy, management of special populations, and appropriate management of common infections – opportunistic and otherwise
- Counsel HIV-infected patients regarding antiretroviral therapy adherence and potential, long-term complications such as the risk for development of specific malignancies, chronic liver or renal disease, and chronic metabolic issues
- Incorporate treatment approaches to address comorbidities and infectious complications
- Determine which HIV-infected patients with hepatitis C virus (HCV) infection are candidates for HCV treatment with directly acting antivirals, design regimens and assessments of response, and describe drug-drug interactions, especially in HIV/HCV coinfected patients on antiretroviral therapy complications
- Integrate treatments for substance use disorders into HIV care settings
- Incorporate treatment approaches to address comorbidities and infectious complications
Conference Schedule
Thursday, May 20, 2021
8:00 AM |
Introduction and Welcome
|
8:15 AM |
History of the HIV Pandemic: Where We Have Been and Where We Are Going
Camilla S. Graham, MD, MPH
|
8:45 AM |
HIV for the Primary Care Provider: Meeting the Challenge of Comprehensive Care
Robin Wigmore, MD
|
9:30 AM |
Question and Answer Session
|
9:40 AM |
Break and Stretch
|
PREVENTING HIV TRANSMISSION
10:00 AM |
Perinatal Transmission – Best Practices for Care, Prevention and Early Interventions*
Roger L. Shapiro, MD, MPH
|
10:30 AM |
New Developments in PrEP and PEP*
Douglas S. Krakower, MD
|
11:00 AM |
Question and Answer Session
|
11:10 AM |
Special Lecture: COVID-19 & HIV: Intersecting Epidemics
Kathryn E. Stephenson, MD, MPH
|
11:50 AM |
Question and Answer Session
|
11:55 AM |
Lunch Break
|
COMPLICATIONS AND CO-MORBIDITIES
12:45 PM |
Guidelines for the Prevention and Treatment of Opportunistic Infections: Practice Essentials*
David S. Yassa, MD
|
1:15 PM |
Management of HPV-Related Complications*
Ami G. Multani, MD
|
1:45 PM |
Question and Answer Session
|
1:55 PM |
Break and Stretch
|
2:00 PM |
Dermatological Diseases Associated with HIV: Lessons from a Dermatologist
Esther E. Freeman, MD, PhD
|
2:45 PM |
Question and Answer Session
|
2:50 PM | Break and Rejuvenation Exercises✻ |
3:10 PM | Cardiovascular Disease: Prevention Strategies Virginia A. Triant, MD, MPH |
3:50 PM | Renal Manifestations of HIV: Recommendations for Optimal Care Melanie P. Hoenig, MD |
4:30 PM | Question and Answer Session |
4:40 PM | Special Lecture: HIV Policy – Clinical Implications* Sean Cahill, PhD |
5:10 PM | Question and Answer Session |
Note: Program changes/substitutions may be made without notice. To view the most up-to-date agenda, please visit the course website.
*Qualifies for Risk Management Credits
✻Optional Wellness Activity
Friday, May 21, 2021
HIV ANTIRETROVIRAL THERAPY (ART)
8:00 AM |
Starting an Initial Antiretroviral Regimen: A Comprehensive Primer
Wendy Stead, MD
|
8:45 AM |
New Therapeutic Agents and When to Switch Antiretroviral Regimens
Christopher F. Rowley, MD, MPH
|
9:30 AM |
Question and Answer Session
|
9:40 AM |
Break and Stretch
|
10:00 AM |
Challenges in HIV Management: Interactive Cases
Wendy Stead, MD
Christopher F. Rowley, MD, MPH |
10:50 AM |
Break
|
VIRAL HEPATITIS WORKSHOP
10:55 AM |
Evaluation and Management of Hepatitis B
Camilla S. Graham, MD, MPH
|
11:40 AM |
Hepatitis C Management Using Direct Acting Agents
Simi Padival, MD
|
12:15 PM |
Question and Answer Session
|
12:25 PM |
Lunch Break
|
1:10 PM |
Management and Diagnosis of Liver Disease
Arthur Y. Kim, MD
|
1:40 PM |
Question and Answer Session
|
1:45 PM |
Managing Coinfection with HBV or HCV: Interactive Cases
Camilla S. Graham, MD, MPH
Simi Padival, MD Arthur Y. Kim, MD |
2:45 PM |
Break and Rejuvenation Exercises✻
|
SEXUAL HEALTH AND HIV
3:05 PM |
HIV and Justice-involved Populations*
Alysse Wurcel, MD, MS
|
4:05 PM |
Sexually Transmitted Infections in At-Risk Patients: New 2021 CDC Guideliness*
Katherine Hsu, MD, MPH, FAAP
|
4:35 PM |
Question and Answer Session
|
Note: Program changes/substitutions may be made without notice. To view the most up-to-date agenda, please visit the course website.
*Qualifies for Risk Management Credits
✻Optional Wellness Activity
Saturday, May 22, 2021
COMPLICATIONS AND CO-MORBIDITIES
8:00 AM |
HIV and Transplantation: New Reasons for HOPE*
Barbra M. Blair, MD
|
8:30 AM |
TB and HIV Coinfection: A Paradigm for Control and Management
Ruvandhi Nathavitharana, MD, MPH
|
9:00 AM |
Question and Answer Session
|
9:10 AM |
Break and Stretch
|
SPECIAL POPULATIONS
9:30 AM |
Transgender Care: Practical Tools for Providers
Julie Thompson, PA-C
|
10:10 AM |
HIV the Aging Population*
Howard Libman, MD, FACP
|
10:50 AM |
Question and Answer Session
|
11:05 AM |
HIV Care in Patients with Opioid Use Disorders*
Alexander Y. Walley, MD, MSc
|
11:50 AM |
Question and Answer Session
|
12:00 PM |
Closing Remarks
|
Note: Program changes/substitutions may be made without notice. To view the most up-to-date agenda, please visit the course website.
*Qualifies for Risk Management Credits
✻Optional Wellness Activity
Course Directors
Douglas S. Krakower, MD
Professor of Dermatology — Harvard Medical School
Director — Wellman Center for Photomedicine MGH
Assistant Professor of Medicine — Harvard Medical School
Staff Physician — Division of Infectious Diseases, Beth Israel Deaconess Medical Center
Simi Padival, MD
Instructor in Medicine — Harvard Medical School
Staff Physician —Division of Infectious Diseases, Beth Israel Deaconess Medical Center
Robin Wigmore, MD
Instructor in Medicine — Harvard Medical School
Staff Physician — Division of Infectious Diseases, Beth Israel Deaconess Medical Center
Event Pricing
QxMD is proud to be partnered with this conference to bring you discounted tickets.
Get a 5% exclusive discount with coupon code: SAVE5
Fee
- At the end of the registration process, a $10 non-refundable processing fee will be added to your registration. Credit card payments are accepted (Visa, MasterCard, or American Express). Postal, telephone, fax, and cash-payment registrations are not accepted. All fees are shown in USD.
- Upon receipt of your paid registration, an email confirmation will be sent to you. Be sure to include an email address that you check frequently. Your email address is used for critical information, including registration confirmation, evaluation, and certificate.
- Refund Policy: Refunds, less an administrative fee of $75 will be issued for all cancellations received two weeks before the start of the course.